Trans-dermal Form of Combined HormonalContraception (EVRA®)


Authors: M. Fanta
Authors‘ workplace: Gynekologicko-porodnická klinika 1. LF UK a VFN v Praze, přednosta prof. MUDr. J. Živný, DrSc.
Published in: Čes. Gynek.2003, , č. 5 s. 341-345
Category:

Overview

Objective:
To present a review of a novel transdermal contraceptive patch containing norelgestromin(150 g/d) and ethinylestradiol (20 g/d).Design: Review article.Setting: Department of Gynecology and Obstetric, 1st Medical Faculty and General Faculty Hospital,Prague.Results: The contraceptive patch exhibits favourable pharmakokinetic profile, maintaining efficaciousserum hormone concentrations under varying conditions and without peaks and throughcharacteristic of oral dosing. Efficacy, cycle control, tolerability and side effect profile were comparableto an established oral contraceptive. Compliance with the weekly administered contraceptivepatch was significantly better than with an oral contraceptive. The reliability of adhesion of thepatch is very high and consistent even under varying conditions (heat, humidity, exercise).

Key words:
transdermal contraception, contraceptive patch, norelgestromin, ethinylestradiol

Full text is not available online.
If interested in a scan of this journal, contact NTO ČLS JEP.

Labels
Paediatric gynaecology Gynaecology and obstetrics Reproduction medicine
Login
Forgotten password

Don‘t have an account?  Create new account

Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account